ClinicalTrials.gg
RecruitingNCT04678167NEVRINGUpdated Mar 19, 2026

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

An interventional study of Caloric test and Measurement of the speed of Nystagmus in Vestibular Neuritis, sponsored by University Hospital, Brest. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by University Hospital, Brest · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Mar 2021; still recruiting 5 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

02

Conditions studied

  • Vestibular Neuritis

Browse trials for

Keywords

  • vestibular hyporeflexia
  • rotational vertigo
  • horizontal-rotational nystagmus
03

In context

Vestibular Neuronitis

34 studies on the registry are indexed under Vestibular Neuronitis; 4 are open to participants now.

This study's planned enrollment of 51 is close to the median of 50 across 27 interventional studies indexed under Vestibular Neuronitis.

Browse Vestibular Neuronitis studies →

Lead sponsor

University Hospital, Brest is the lead sponsor of 601 studies on the registry; 136 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients,
  • patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
  • patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
  • patient with a postural deviation towards the affected ear;
  • vestibular hyporeflexia measured at the caloric tests greater than 25%
  • patient who has given free, enlighten and written consent

Exclusion criteria

Exclusion Criteria:

  • patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
  • patient with associated hearing loss or tinnitus
  • patient with an motor ocular abnormality of central origin
  • patient refusal or inability to consent
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
51 participants (estimated)

Study arms

  • Experimental
    Boarding ring glasses

    Realization of the following examinations WITH Boarding ring glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

    Diagnostic Test: Caloric test · Diagnostic Test: Measurement of the speed of Nystagmus · Diagnostic Test: Angle of deviation at Fukuda · Diagnostic Test: Alexander's degree of nystagmus · Other: EHTEV questionnaire · Other: EEV questionnaire · Other: anxiety VAS

  • Placebo comparator
    Placebo glasses

    Realization of the following examinations WITH Placebo glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

    Diagnostic Test: Caloric test · Diagnostic Test: Measurement of the speed of Nystagmus · Diagnostic Test: Angle of deviation at Fukuda · Diagnostic Test: Alexander's degree of nystagmus · Other: EHTEV questionnaire · Other: EEV questionnaire · Other: anxiety VAS

  • Other
    No glasses

    Realization of the following examinations WITHOUT glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

    Diagnostic Test: Caloric test · Diagnostic Test: Measurement of the speed of Nystagmus · Diagnostic Test: Angle of deviation at Fukuda · Diagnostic Test: Alexander's degree of nystagmus · Other: EHTEV questionnaire · Other: EEV questionnaire · Other: anxiety VAS

Interventions

  • Diagnostic testCaloric test

    Lying, patientwill be placed so that he can introduce water (hot then cold) into his external ear canal. It is the reaction of the vestibular system (sensory organ responsible for balance) which is then measured with a helmet placed over his eyes and which measures the nystagmus (movement of the eye) which reflects vestibular activity.

    Also known as: Barany test

  • Diagnostic testMeasurement of the speed of Nystagmus

    A helmet with an infrared camera will be placed in front of patient eyes. This will allow visualizing on screen and measuring eye movements spontaneous or induced in the dark by various tests.

  • Diagnostic testAngle of deviation at Fukuda

    The patient will be asked to trample on the spot (30 steps) with the indexes pointed forward. In the event of vestibular asymmetry, the patient turns at a varying angle to the right or to the left. This will then measure what is called the angle of deflection of the fukuda.

  • Diagnostic testAlexander's degree of nystagmus

    there are 3 degrees: * Degree I: nystagmus that exists only when the eyes are turned to the right. * Degree II: also exists when the eyes are to the right or to the front. * Degree Ill: exists when the eyes are on the right, front, or left

  • OtherEHTEV questionnaire

    Handicap Scale for Balance Disorders and Vertigo

  • OtherEEV questionnaire

    European Vertigo Assessment Questionnaire

  • Otheranxiety VAS

    visual analog scale of anxiety

06

What researchers measure

Primary outcomes

  1. Variation of the angle of deviation at the Fukuda test between J0 and J7 (value at J0 minus value at J7).

    Time frame: 7 day

Secondary outcomes

  1. Speed of nystagmus

    Time frame: 1 year

  2. Alexander's degree of nystagmus

    Measure of the degree of intensity of nystagmus. There are 3 degrees : * Degree I: nystagmus which exists only when the eyes are turned to the right. * Degree II: also exists when the eyes are to the right or to the front. * Degree Ill: exists when the eyes are on the right, front, or left.

    Time frame: 1 year

  3. Duration of hospitalization (for hospitalized patients)

    Time frame: 1 year

  4. Anxiety visual analog scale

    0 = no anxiety, 10 = maximum anxiety imaginable

    Time frame: 1 year

  5. Handicap related to Balance Disorders and Vertigo scale (EHTEV questionnaire)

    It helps to determine the physical, emotional and functional difficulties experienced in everyday life. EHTEV questionnaire is scored on 100 points. The physical score from 0 to 28 points, the emotional score from 0 to 36 points and the functional score from 0 to 36 points. ( 0 = no difficulty).

    Time frame: 1 year

  6. European Vertigo Evaluation Scale (EEV questionnaire)

    Makes it possible to quantify vertigo and the associated vestibular symptoms and to monitor their evolution. EEV questionnaire is scored on 20 points (0 = no symptoms, 20 = maximum symptoms)

    Time frame: 1 year

  7. Vestibular deficit at caloric tests

    measures 7of nystagmus (= fluttering of the eye) which reflects vestibular activity

    Time frame: 1 year

  8. Variation from J0 of the angle of deviation at the Fukuda measured at J14, M1, M3, M6, M12

    Time frame: 1 year

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected data that underlie results in a publication

Supporting information: Study protocol

Time frame: Data will be available after the publication of result and ending fifteen years following the last visit of the last patient

Access criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04678167
Responsible party
Sponsor
First posted
Dec 21, 2020
Start date
Mar 10, 2021
Primary completion
Mar 17, 2028 (estimated)
Completion
May 10, 2029 (estimated)
Last update
Mar 19, 2026

Study contacts

Jean-Christophe LECLERE, Dr
Contact
jean-christophe.leclere@chu-brest.fr
02.98.22.33.78
Jean-Christophe LECLERE, Dr
principal investigator · University Hospital, Brest

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion